Pfizer Inc (PFE)

PFE (NYSE:Drugs) EQUITY
$34.44
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | PFE Avg Daily Volume: 25,950,500
Last Update: 05/28/15 - 4:03 PM EDT
Volume: 0
YTD Performance: 10.56%
Open: $0.00
Previous Close: $34.44
52 Week Range: $27.51 - $35.53
Oustanding Shares: 6,157,669,933
Market Cap: 211,208,078,702
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 8 8
Moderate Buy 0 1 1 1
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.00 2.00 1.93 1.93
Latest Dividend: 0.28
Latest Dividend Yield: 3.27%
Dividend Ex-Date: 05/06/15
Price Earnings Ratio: 23.82
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
23.82 23.80 26.97
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.35% 16.31% 55.63%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.80 -0.26 -0.10
Net Income -58.50 0.04 0.01
EPS -55.50 0.13 0.04
Earnings for PFE:
EBITDA 19.04B
Revenue 49.61B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.51 $0.51 $2.04 $2.29
Number of Analysts 8 7 9 10
High Estimate $0.55 $0.53 $2.08 $2.53
Low Estimate $0.48 $0.48 $2.01 $2.13
Prior Year $0.58 $0.57 $2.26 $2.04
Growth Rate (Year over Year) -11.21% -10.03% -9.73% 12.16%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | May 21, 2015 | 6:49 PM EDT

Deals coming fast and furious in the best group in town.

By

Jim Cramer

 | May 15, 2015 | 3:11 PM EDT

With a weak dollar, calm oil and tame rates, we're doing fine.

By

Jill Malandrino

 | May 14, 2015 | 3:51 PM EDT

Galapagos (GLPG) is the latest biotech stock to list on the Nasdaq Market with an impressive first day of trading as the stock traded up 20%.

By

Jim Cramer

 | May 7, 2015 | 9:00 AM EDT

Perspectives from Wall Street looks at how investors at any age can find opportunities in the health care sector.

By

David Peltier

 | Apr 27, 2015 | 4:55 PM EDT

Apple is higher after-hours on better-than-expected results.

By

David Peltier

 | Apr 24, 2015 | 4:33 PM EDT

Big day for Microsoft -- Xerox, not so much.

bullishPfizer estimates, target upped at BMO

Apr 23, 2015 | 7:25 AM EDT

PFE estimates were boosted through 2016, BMO Capital said. Ibrance launch should be stronger than expected. Outperform rating and new $38 price target. 

updatePFE Investor Mtg.

Apr 23, 2015 | 6:27 AM EDT

PFE - Pfizer Inc Annual Shareholders Meeting - 8:30AM

By

Robert Lang

 | Apr 22, 2015 | 10:52 AM EDT

Gilead's Relative Strength Index slope is very strong.

By

Robert Lang

 | Apr 22, 2015 | 10:00 AM EDT

Gilead's Relative Strength Index slope is very strong.

A "mega car merger" is being discussed on Fast Money tonite. The shares are trading up in ...

All better than expected!!

Hope you'll join me for a bigtime webinar after the close today, we'll be talkin' markets ...

McIlroy shoots 80 in fist round of the Irish Open.
...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.